| Tag | Content |
|---|
EnhancerAtlas ID | HS105-07274 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr1:224022260-224023110 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| POU2F2 | MA0507.1 | chr1:224022262-224022275 | TATATTTGCATAT | + | 6.3 | | ZNF263 | MA0528.1 | chr1:224022664-224022685 | CCTCCCTGGTTTTCCTCCTCC | - | 6.56 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09755 | chr1:224018879-224024980 | CD14 | | SE_18793 | chr1:224018897-224025157 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19882 | chr1:224022236-224024239 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I223831 | chr1 | 224018704 | 224025501 |
|
Enhancer Sequence | TTTATATTTG CATATTTTGA ATTTCAGGGA ATTCCATTTC AATTACAAGA AATATTAAGA 60
CCTAAAATTT ATTTTAAATT ATCTACTCCA CAGTTATAGC CTCGAGTCAC CAAATGAGGA 120
ATCTAAAATA GCCACTTTTC CTCACTTCTC TCCCCAGAGT AGCTCACCTG ATTCCTACTC 180
TGTCCTGTAG TGTCAATTCA TCCCCATCCT TCCAGAATAA CTCAAAGACC ATAAAACTTC 240
CTCCAATCCA TCCATCCCTA CCCACACACT CACCTCCAGC CAGAAGTAAA TGTTCTCTTT 300
GCTTCTCTGA CAACCATTCA CACTGTAGTT GTCTGTATCC CTGTCTTATC TGTCCTACTG 360
GTCTATACAT TCTTTAGTAC ACATGTTTTG GTTCTTAAAT GCCTCCTCCC TGGTTTTCCT 420
CCTCCTACAT TATAACTCAC TCCCCAAAAA ACTCTGTCAG ATCTCACACA AAGCAAATAT 480
GCAATACATG TTTGTTGGAC TGAACTGAAA CTGTGACGCA GGGATTCAAA GTTCCACGAA 540
GAGGAGAAAG TTAACAGGCA ACAAGAACAT GACAAAGAGG ATGTTCACAT CCTGAAGCAT 600
CAAGAAATGT TTATCTATAA ATGGTATTAC TTCACAGTGA ATGTTTTCAA AGCCAGACAA 660
TGTCTCAAAG AATTCTGCTT TAAGTAAAAT TAAGAAACCT TTTCTCTTCT TTCAACTATG 720
CCTGAAGCTG AATTTAGATA AGTTTCAAAT TCTGAACGTA TCCTCTAAAG CAACTCATCT 780
TAGGTTACTC TGCTTCAATA TCTGTCATAA ACAATCAATG TATAAAGCAA AAGAACAAAT 840
ACATTTAGTT 850
|
